Loading
companiesCompany
Bpifrance
Bpifrance is the French state investment bank, created in 2012, which combines loans, guarantees, innovation grants and equity investment. Through its biotech funds and the France 2030 programme it co-invests, usually alongside private venture funds, in French oncology drug, diagnostics and radiotherapy hardware developers, which is why it appears in French oncology financing rounds.
Overview
Bpifrance is France's public investment bank, created in 2012, which combines loans, guarantees, innovation grants and direct and fund-of-funds equity investment. Through its innovation and biotech funds and the France 2030 programme it co-invests in French life-science companies, including oncology drug, diagnostics and radiotherapy hardware developers, usually alongside private venture funds. It is recorded as a public fund rather than a venture firm; portfolio links in OnCo are derived from the startup records that name it.
Portfolio (3)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adcendo Copenhagen, DK | Growth stage | biotech | Sarcomas (soft tissue, bone, GIST) | Series C 2026, $75M |
| Alentis Therapeutics Basel, CH | Growth stage | biotech | Series D 2024, $181M | |
| THERYQ Paris, FR | Large private | devices | none on record |
Similar pages
- CompanyNovo Holdings
Shares Alentis Therapeutics, Adcendo.
- CompanyJeito Capital
Shares Alentis Therapeutics, Adcendo.
- CompanyOrbiMed
Shares Alentis Therapeutics, Adcendo.
- CompanyRA Capital Management
Shares Alentis Therapeutics, Adcendo.